Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Bath & Body Works (NYSE:BBWI - Get Rating) was downgraded by Zacks Investment Research from a "hold" rating to a "sell" rating in a report issued on Wednesday, Zacks.com reports.

According to Zacks, "Bath & Body Works is a specialty retailers and home to America's Favorite Fragrances(R) offering exclusive fragrances for the body and home, fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. Bath & Body Works, formerly known as L BRANDS INC, is based in COLUMBUS, Ohio. "

A number of other brokerages have also weighed in on BBWI. B. Riley decreased their price objective on shares of Bath & Body Works from $76.00 to $67.00 and set a "buy" rating for the company in a report on Friday, May 20th. Wells Fargo & Company decreased their price objective on shares of Bath & Body Works from $85.00 to $70.00 and set an "overweight" rating for the company in a report on Tuesday, April 5th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Bath & Body Works from $78.00 to $61.00 in a report on Thursday, May 19th. Citigroup reduced their price target on shares of Bath & Body Works from $87.00 to $54.00 and set a "buy" rating for the company in a report on Monday. Finally, Telsey Advisory Group reduced their price target on shares of Bath & Body Works from $70.00 to $60.00 and set an "outperform" rating for the company in a report on Thursday, May 19th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and seventeen have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Buy" and a consensus target price of $66.20.

Shares of Bath & Body Works stock traded up $3.15 during trading on Wednesday, hitting $39.30. The stock had a trading volume of 5,418,872 shares, compared to its average volume of 4,964,856. The firm's fifty day simple moving average is $49.57 and its 200-day simple moving average is $58.13. The stock has a market cap of $9.37 billion, a PE ratio of 8.56, a PEG ratio of 1.11 and a beta of 1.56. Bath & Body Works has a 12 month low of $35.46 and a 12 month high of $82.00.

Bath & Body Works (NYSE:BBWI - Get Rating) last announced its quarterly earnings data on Wednesday, May 18th. The company reported $0.64 earnings per share for the quarter, beating analysts' consensus estimates of $0.53 by $0.11. Bath & Body Works had a net margin of 15.41% and a negative return on equity of 83.19%. Analysts forecast that Bath & Body Works will post 3.9 earnings per share for the current year.

In other Bath & Body Works news, CFO Wendy C. Arlin sold 6,000 shares of the business's stock in a transaction that occurred on Tuesday, April 19th. The shares were sold at an average price of $55.00, for a total transaction of $330,000.00. Following the sale, the chief financial officer now owns 98,888 shares of the company's stock, valued at approximately $5,438,840. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.37% of the stock is currently owned by insiders.

Several institutional investors and hedge funds have recently bought and sold shares of BBWI. AlphaCrest Capital Management LLC acquired a new position in shares of Bath & Body Works in the 3rd quarter valued at $363,000. American Century Companies Inc. acquired a new position in Bath & Body Works during the third quarter worth $10,493,000. Public Sector Pension Investment Board acquired a new position in Bath & Body Works during the third quarter worth $2,818,000. Mitsubishi UFJ Trust & Banking Corp acquired a new position in Bath & Body Works during the third quarter worth $11,375,000. Finally, Hennion & Walsh Asset Management Inc. acquired a new position in Bath & Body Works during the third quarter worth $371,000. Hedge funds and other institutional investors own 97.11% of the company's stock.

Bath & Body Works Company Profile (Get Rating)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Featured ArticlesGet a free copy of the StockNews.com research report on Bath & Body Works (BBWI)Short-Covering Begins In Big Lots Institutions Ring The Register On Toll Brothers StockAgilent Technologies Is Bottoming But Don’t Buy It YetDick’s Sporting Goods Falls Flat On Weak Guidance Indie Semiconductor Stock is Putting in a Bottom

Get a free copy of the Zacks research report on Bath & Body Works (BBWI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Each market day you'll get a one-minute market summary to help you invest wisely.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.